Clinical, ethical, and quality-of-life outcomes in unresectable hepatocellular carcinoma: the LEAP-012 trial. Onder AH. Lancet 2025;406:693.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Onder AH. Clinical, ethical, and quality-of-life outcomes in unresectable hepatocellular carcinoma: the LEAP-012 trial. Lancet 2025;406:693.
PMID: 40818848